Complaint #: 398975Based on record review, interview, and document review, the facility failed to acquire pain medications as ordered by the physician for one of 16 sampled residents (Resident (R)16). R16 was admitted to the facility with diagnoses including pancreatic adenocarcinoma and had admitting orders for pain medications, in particular Dilaudid (an opioid pain medication used to treat moderate to severe pain), and staff failed to acquire the medication. This failure of R16 not receiving the ordered medication for pain caused harm and increased the likelihood for a painful death.The facility's Administrator, Director of Nursing (DON), and Regional Nurse Consultant (RNC) were informed on 09/25/25 at 7:40 PM an Immediate Jeopardy (IJ) existed at F755 Pharmacy Services related to the… …
F755 citations in New Jersey
Pharmacy services · Pharmacy Service Deficiencies
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
New Jersey cites F755 more often than its own record predicts
1.50 times the share F755 takes of citations nationally.
Of every deficiency written in New Jersey in 2025, this is the portion that was F755.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New Jersey surveyors wrote
F755 findings written in New Jersey, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Complaints:2794269, 2679147, 2588899, 2639889, 2789654, 2789700 Based on interviews, review of medical records, and review of pertinent facility documents on 03/05/2026, 03/09/2026 and 03/10/2026, it was determined that the facility failed to a.) ensure that physician ordered medication was obtained and available to be administered and b.) maintain records of, receipt, accountability, and removal from inventory of controlled drugs, for 4 out of 5 residents (Resident #9, Resident #10, Resident #15, and Resident #18) reviewed for methadone (opioid medication that treats severe, chronic pain and substance use disorder). The deficient practice was evidenced by the following:A. …
Complaint #:3073599Based on interviews, review of medical records, and review of pertinent facility documentation on 08/18/26, it was determined that the facility failed to a.) ensure that a physician ordered medication was obtained and available to be administered and b.) ensure the physician was notified that a resident's medication was not being administered as ordered. This deficient practice was identified for 1 of 5 residents (Resident #2), and was evidenced by the following: A review of the facility's policy titled Administering Medications, with an updated date of 4/2024 included under Policy Interpretation and Implementation: 21. …
The short window
Recent years
| Year | Share of New Jersey citations | vs expected |
|---|---|---|
| 2023 | 4.36% | 2.07× |
| 2024 | 3.77% | 1.77× |
| 2025 | 3.53% | 1.50× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else New Jersey surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction